+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anatomic Pathology - Global Strategic Business Report

  • PDF Icon

    Report

  • 377 Pages
  • June 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4805116
The global market for Anatomic Pathology was estimated at US$29.8 Billion in 2025 and is projected to reach US$53.1 Billion by 2032, growing at a CAGR of 8.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Anatomic Pathology Market - Key Trends and Drivers Summarized

What Are the Fundamentals of Anatomic Pathology?

Anatomic pathology is a critical medical specialty that focuses on diagnosing diseases through the examination of organs, tissues, and bodily fluids. This field involves several key techniques, including gross examination, microscopic analysis, and molecular pathology. Pathologists, who specialize in anatomic pathology, play an essential role in identifying various conditions such as cancers, infections, and autoimmune diseases by analyzing biopsy samples and surgical specimens. The importance of anatomic pathology cannot be overstated, as it provides definitive diagnoses that guide treatment plans and influence patient outcomes. With advancements in technology and increased understanding of disease mechanisms, anatomic pathology continues to evolve, integrating more precise and sophisticated diagnostic methods.

How Is Technology Revolutionizing Anatomic Pathology?

Technological innovations are profoundly transforming anatomic pathology, making it more accurate and efficient. Digital pathology, which involves the conversion of glass slides into digital images, is revolutionizing the way pathologists analyze specimens. This technology facilitates remote consultations, digital archiving, and image analysis using artificial intelligence (AI). AI algorithms, in particular, are enhancing diagnostic accuracy by identifying patterns that might be missed by the human eye. Additionally, advances in molecular pathology are enabling more detailed genetic and molecular analysis of tissues, leading to more precise diagnoses and personalized treatment plans. The integration of these technologies not only improves the speed and accuracy of diagnoses but also enhances collaboration among pathologists and other medical professionals.

Why Are Precision Medicine and Personalized Treatments Important for Anatomic Pathology?

The shift towards precision medicine and personalized treatments is significantly impacting anatomic pathology. Precision medicine aims to tailor medical treatment to the individual characteristics of each patient, which requires a deep understanding of the genetic, environmental, and lifestyle factors that influence disease. Anatomic pathology provides the necessary insights into these factors by analyzing tissue samples at the molecular level. This approach allows for the identification of specific biomarkers that can predict how a patient will respond to certain treatments. Personalized treatment plans, guided by anatomic pathology findings, are becoming increasingly common in oncology, where targeted therapies are developed based on the molecular profile of a patient`s tumor. This trend not only improves patient outcomes but also drives demand for advanced anatomic pathology services.

What Factors Are Driving Growth in the Anatomic Pathology Market?

The growth in the anatomic pathology market is driven by several factors related to technological advancements, end-use applications, and evolving healthcare practices. The increasing prevalence of chronic diseases, particularly cancer, is a major driver, as the need for accurate and early diagnosis becomes more critical. Technological advancements, such as digital pathology and AI, are propelling market growth by improving diagnostic accuracy and efficiency. The trend towards precision medicine and personalized treatments is expanding the demand for detailed tissue analysis and molecular diagnostics. Additionally, the aging population is contributing to market growth, as older individuals are more likely to require pathological assessments. The rise in healthcare spending and the increasing adoption of pathology services in emerging markets further accelerate market expansion. Moreover, the growing trend of laboratory automation and the integration of big data analytics in pathology are enhancing operational workflows and supporting the scaling of pathology services to meet increasing demand. These factors collectively drive the robust growth of the anatomic pathology market.

Report Scope

The report analyzes the Anatomic Pathology market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Offering (Services, Consumables, Instruments); Application (Disease Diagnostics, Medical Research); End-Use (Hospital Laboratories, Clinical Laboratories, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Instruments Component segment, which is expected to reach US$22.4 Billion by 2032 with a CAGR of a 8.8%. The Consumables Component segment is also set to grow at 6.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $9.2 Billion in 2025, and China, forecasted to grow at an impressive 13.5% CAGR to reach $13.8 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Anatomic Pathology Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Anatomic Pathology Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Anatomic Pathology Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agilent Technologies, Inc., BioGenex, Bio SB, Danaher Corporation, F. Hoffmann-La Roche AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Anatomic Pathology market report include:

  • Agilent Technologies, Inc.
  • BioGenex
  • Bio SB
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • PHC Holdings Corporation
  • Quest Diagnostics, Inc.
  • Sakura Finetek Japan Co., Ltd.

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 1,864 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • Anatomic Pathology - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Focus on Early Diagnosis and Preventive Healthcare Generates Demand for Anatomic Pathology
  • Emergence of Digital Pathology Throws the Spotlight on Anatomic Pathology
  • Advances in AI and Machine Learning Propel Growth in Anatomic Pathology
  • Integration of Molecular Diagnostics Expands Addressable Market Opportunity
  • Economic Burden of Chronic Diseases Propels Need for Accurate Diagnostic Services
  • Aging Population Sustains Growth in Anatomic Pathology Market
  • Shift Towards Personalized Treatments Impacts Anatomic Pathology
  • Technological Innovations in Imaging and Analysis Drives Adoption of Anatomic Pathology
  • Laboratory Automation Trends Accelerate Demand for Efficient Pathology Solutions
  • Rise of Telepathology and Remote Consultations Spur Growth in Anatomic Pathology
  • Innovations in Tissue and Biomarker Analysis Drives Adoption of Advanced Pathology Methods
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 2: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 3: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 4: World Anatomic Pathology Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 5: World Recent Past, Current & Future Analysis for Anatomic Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Anatomic Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Anatomic Pathology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Instruments Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Instruments Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Instruments Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Consumables Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Consumables Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Consumables Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Disease Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Disease Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Disease Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAIN
RUSSIA
REST OF EUROPE
AUSTRALIA
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Anatomic Pathology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • BioGenex
  • Bio SB
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • PHC Holdings Corporation
  • Quest Diagnostics, Inc.
  • Sakura Finetek Japan Co., Ltd.

Table Information